Factor V Leiden, prothrombin gene G20210A variant, and methylenetetrahydrofolate reductase C677T genotype in young adults with ischemic stroke

Clinical and Applied Thrombosis/Hemostasis

Volumn 7, Issue 4, 2001, Pages 346-350

  Lopaciuk, Stanislaw ^a   Bykowska, Ksenia ^a   Windyga, Jerzy ^a   Kwiecinski, Hubert ^b   Mickielewicz, Anatol ^b   Jedrzejowska, Hanna ^b   Czlonkowska, Anna ^c   Mendel, Tadeusz ^c   Kuczynska Zardzewialy, Arletta ^d   Szelagowska, Dorota ^d   Shröder, Winnie ^d   Herrmann, Falko H ^e  

^a Institute of Hematology and Blood Transfusion   (Poland)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

^c INSTITUTE OF PSYCHIATRY AND NEUROLOGY   (Poland)

^d Wolski Hospital   (Poland)

^e UNIVERSITY OF GREIFSWALD   (Germany)

Author keywords

Inherited thrombophilia; Ischemic stroke; Young adults

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); BLOOD CLOTTING FACTOR 5 LEIDEN; PROTHROMBIN; BLOOD CLOTTING FACTOR 5; METHYLENE THF REDUCTASE (NADPH); METHYLENE-THF REDUCTASE (NADPH); OXIDOREDUCTASE;

ADULT; ARTICLE; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; FEMALE; GENE MUTATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; ADOLESCENT; BLOOD; BRAIN ISCHEMIA; CASE CONTROL STUDY; GENETIC PREDISPOSITION; GENETICS; POINT MUTATION; RISK FACTOR;

ADOLESCENT; ADULT; AMINE OXIDOREDUCTASES; BRAIN ISCHEMIA; CASE-CONTROL STUDIES; CEREBROVASCULAR ACCIDENT; FACTOR V; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMAN; MALE; MIDDLE AGE; POINT MUTATION; PREVALENCE; PROTHROMBIN; RISK FACTORS; VARIATION (GENETICS);

EID: 0034780697     PISSN: 10760296     EISSN: None     Source Type: Journal    
DOI: 10.1177/107602960100700418     Document Type: Article

References (41)

1. Molecular risk factors for thrombosis
2. Mutation in blood coagulation factor V associated with resistance to activated protein C
3. A common genetic variation in the 3′ untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis
4. Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men
5. G20210A mutation in the prothrombin gene and risk of myocardial infarction, stroke, and venous thrombosis in a large cohort of US men
6. Homocysteinemia as a risk factor for atherosclerosis: A review
7. A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase
8. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial
9. A simple salting out procedure for extracting DNA from human nucleated cells
10. Stroke in young adults
11. Cerebral infarction associated with protein C deficiency
12. Ischemic stroke due to deficiency of coagulation inhibitors: Report of 10 young adults
13. C677T MTHFR mutation and factor V Leiden mutation in patients with TIA/minor stroke: A case-control study
14. Factor V Leiden gene mutation and thrombin generation in relation to the development of acute stroke
15. Ischemic Stroke in the elderly. Role of common factor V mutation causing resistance to activated protein C
16. Arg506Gln factor V mutation and cerebral ischemia in the young
17. Activated protein C resistance in childhood stroke
18. Ischemic stroke in infancy and childhood: Role of the Arg 506 to Gln mutation in the factor V gene
19. Frequency of resistance to activated protein C due to factor V mutation in young patients with ischemic stroke
20. Factor V Leiden mutation: An unrecognized cause of hemiplegic cerebral palsy, neonatal stroke, and placental thrombosis
21. Prevalence of factor V Leiden mutation in young adults with cerebral ischemia: A casecontrol study on 225 patients
22. Factor V Leiden and prothrombin gene G20210A variant in children with ischemic stroke
23. Inherited prothrombotic conditions and premature ischemic stroke. Sex difference in the association with factor V Leiden
24. Physiological anticoagulants and activated protein C resistance in childhood stroke
25. Factor V Leiden, prothrombin 20210G→A and MTHFR C677T mutations in childhood stroke
26. Prothrombin G20210A mutant genotype is a risk factor for cerebrovascular ischemic disease in young patients
27. Thrombophilic disorders in children with cerebral infarction
28. The mutation Ala677→Val in the methylene tetrahydrofolate reductase gene: A risk factor for arterial disease and venous thrombosis
29. Methylenetetrahydrofolate reductase gene polymorphism and ischemic stroke in Japanese
30. The mutation C677→T in the methylene tetrahydrofolate reductase gene and stroke
31. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentration
32. Plasma homocyst(e)ine concentration, but not MTHFR genotype, is associated with variation in carotid plaque area
33. Common methylenetetrahydrofolate reductase gene mutation leads to hyperhomocysteinemia but not to vascular disease. The result of meta-analysis
34. Effect of the MTHFR C677T variant on risk of venous thromboembolism: Interaction with factor V Leiden and prothrombin (F2G20210A) mutations
35. Epidemiology of stroke
36. Factor V Leiden and venous thrombosis in Danish centenarians
37. Prothrombin gene mutation (G20210A) in healthy centenarians
38. World distribution of factor V Leiden
39. Prevalence of factor V Leiden mutation in various populations
40. Geographic distribution of the 20210 G to A prothrombin variant
41. Analysis of the 677 C→T mutation of the methylenetetrahydrofolate reductase gene in different ethnic groups